What is LIVN's health score?

LivaNova PLC (LIVN) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LIVN's estimated fair value?

Based on our 5-year discounted cash flow model, LivaNova PLC's estimated fair value is $12.5 per share, representing a -84.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LIVN undervalued or overvalued?

Our model currently rates LIVN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

LivaNova PLC (LIVN)

Healthcare Overvalued low healthy

$79.41

Updated: 2026-07-16

TradeApes Score

Financial Strength

80 Strong

Operating Trend

71 Healthy

Relative Value

60 Healthy

Capital Allocation

60 Healthy

Risk Management

70 Healthy

Est. Fair Value $12.5

DCF Upside -84.3%

Sector Rank #515 of 12118

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.